A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase IV Clinical Trial to Evaluate the Immunogenicity and Safety of a Live Attenuated Herpes Zoster Vaccine in Adults Aged 40 Years and Older

NCT06961721 · clinicaltrials.gov ↗
PHASE4
Phase
NOT_YET_RECRUITING
Status
600
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Changchun BCHT Biotechnology Co.

Collaborators